Hyderabad, May 9 -- Dr. Reddy's Laboratories and Nestle India on Friday announced the launch of 'Celevida GLP ', a specialised nutritional product designed to support muscle mass maintenance and nutritional needs of people undergoing GLP-1/GIP therapy for management of type 2 diabetes and obesity in India.
The product has been launched by Dr. Reddy's and Nestle Health Science Limited, a joint venture between the two companies, as the adoption of GLP-1/GIP-based therapies continues to rise in the country.
According to the companies, there is an increasing need for integrated patient care beyond medicines, including nutrition support, clinical monitoring and long-term lifestyle management to ensure sustainable outcomes for people with diabe...